Literature DB >> 8591085

Improved survival after resection of colorectal liver metastases.

G M Fuhrman1, S A Curley, D C Hohn, M S Roh.   

Abstract

BACKGROUND: The goal of this study was to determine if staging with intraoperative ultrasound (IOUS), assessment of porta hepatis lymph nodes, and evaluation of resection margins can improve selection of patients likely to benefit from resection of colorectal liver metastases.
METHODS: A retrospective evaluation was performed on patients undergoing celiotomy with intent to resect colorectal liver metastases. Patients were considered unresectable if extrahepatic disease was identified by peritoneal exploration or if IOUS demonstrated greater than four lesions or the inability to achieve negative margins. Tumor-negative margins were confirmed by pathologic evaluation. Actuarial 5-year survival was calculated using the method of Kaplan and Meier.
RESULTS: Median follow-up is 25 months. Of the 151 patients undergoing operative exploration, 107 (71.0%) underwent liver resection (all margins tumor negative). Three operative deaths occurred in this group (2.8%). The disease of 30 patients (19.8%) was considered unresectable due to extrahepatic involvement, and that of 14 patients (9.2%) was demonstrated by IOUS to be unresectable. Five-year actuarial survival was 44% for the resected group and 0% for the unresectable patients (p < 0.0001).
CONCLUSIONS: IOUS, portal node assessment, and pathologic margin evaluation improves the selection of patients likely to benefit from resection of colorectal liver metastases.

Entities:  

Mesh:

Year:  1995        PMID: 8591085     DOI: 10.1007/bf02307088

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases.

Authors:  B Cady; M D Stone; W V McDermott; R L Jenkins; A Bothe; P T Lavin; E J Lovett; G D Steele
Journal:  Arch Surg       Date:  1992-05

2.  The systematic use of operative ultrasound for detection of liver metastases during colorectal surgery.

Authors:  G Boldrini; A M de Gaetano; I Giovannini; M Castagneto; C Colagrande; G Castiglioni
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

3.  Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices.

Authors:  S A Curley; J L Chase; M S Roh; D C Hohn
Journal:  Surgery       Date:  1993-11       Impact factor: 3.982

4.  Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings.

Authors:  B A Ward; D L Miller; J A Frank; A J Dwyer; J T Simmons; R Chang; T H Shawker; P Choyke; A E Chang
Journal:  Surgery       Date:  1989-02       Impact factor: 3.982

5.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.

Authors:  J P Heiken; P J Weyman; J K Lee; D M Balfe; D Picus; E M Brunt; M W Flye
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

6.  Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma.

Authors:  J T Vetto; K S Hughes; R Rosenstein; P H Sugarbaker
Journal:  Dis Colon Rectum       Date:  1990-05       Impact factor: 4.585

7.  Perioperative predictors of morbidity following hepatic resection for neoplasm. A multivariate analysis of a single surgeon experience with 105 patients.

Authors:  J V Sitzmann; P S Greene
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

Review 8.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

9.  Resection of hepatic metastases from colorectal cancer.

Authors:  M A Adson; J A van Heerden; M H Adson; J S Wagner; D M Ilstrup
Journal:  Arch Surg       Date:  1984-06

10.  Operative ultrasound establishes resectability of metastases by major hepatic resection.

Authors:  S T Brower; O Dumitrescu; S Rubinoff; J A McElhinney; A H Aufses
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

View more
  18 in total

Review 1.  Cryosurgery in the treatment of liver metastasis from colorectal cancer.

Authors:  T S Ravikumar; R Sotomayor; R Goel
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

Review 2.  Treatment for multiple bilobar liver metastases of colorectal cancer.

Authors:  Hiroshi Shimada; Kuniya Tanaka; Kenichi Matsuo; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2005-12-01       Impact factor: 3.445

3.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

4.  Intraoperative margin re-resection for colorectal cancer liver metastases.

Authors:  Sajid A Khan; Jeffrey B Matthews
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

5.  The role of positron emission tomography in colorectal carcinoma.

Authors:  Oussama M Nachar
Journal:  Ochsner J       Date:  2002

6.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

7.  Intraoperative surgical margin re-resection for colorectal liver metastasis: is it worth the effort?

Authors:  Georgios A Margonis; Gaya Spolverato; Yuhree Kim; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-12-02       Impact factor: 3.452

8.  The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.

Authors:  G Kong; C Jackson; D M Koh; V Lewington; B Sharma; G Brown; D Cunningham; G J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-18       Impact factor: 9.236

Review 9.  Potentially curable metastatic colorectal cancer.

Authors:  Matthew Katz; Jean-Nicolas Vauthey
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

10.  Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?

Authors:  Miriam López-Gómez; Paloma Cejas; María Merino; David Fernández-Luengas; Enrique Casado; Jaime Feliu
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.